Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Glaxosmithkline Plc stacks up to the competition and put relevant competitor and industry information at your fingertips.
Block Drug Copmany Inc, Corixa Corporation, GlaxoSmithKline, GlaxoSmithKline Capital Inc, GlaxoSmithKline Consumer Healthcare Holdings LLC, GlaxoSmithKline Holdings, GSK Consumer Health, GSK Equity Investments, Human Genome Sciences Inc, PF Consumer Healthcare, Stiefel Labratories, Tesaro, ViiV Healthcare Company
Glaxosmithkline is a public company headquartered in United Kingdom with an estimated 70,000 employees. In the US, the company has a notable market share in at least one industry: Brand Name Pharmaceutical Manufacturing, where they account for an estimated 6.7% of total industry revenue and are considered a Disruptor because they display lower to medium market share that’s rising rapidly, but weaker profits compared to some of their peers.
Of the 8 core revenue-generating products and services in the Brand Name Pharmaceutical Manufacturing industry, Glaxosmithkline Plc offers:
Strengths and weaknesses take into account internal factors, and are based on Glaxosmithkline Plc's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Brand Name Pharmaceutical Manufacturing industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.